Evidence map›Paper›PMID 39979018›Full record

Observational studyBMJ global health2025

Differentiated community-based point-of-care early infant diagnosis to improve HIV diagnosis and ART initiation among infants and young children in Zambia: a quasi-experimental cohort study.

Albert Manasyan, Tannia Tembo, Helen Dale, Jake M Pry, Megumi Itoh, Dhelia Williamson, Herbert Kapesa, Josip Derado, Rachel Suzanne Beard, Shilpa Iyer and 3 more

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in BMJ global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03133728 (To Improve Rates of Antiretroviral Therapy Initiation for HIV-1 Infected Infants Through Point-of-Care Diagnosis), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03133728 completednot on this map

To Improve Rates of Antiretroviral Therapy Initiation for HIV-1 Infected Infants Through Point-of-Care Diagnosis

TypeobservationalSponsorUniversity of Alabama at BirminghamRan2019 to 2020Enrolled1,682ConditionsHIV Infections, HivArmsAlere Q Testing
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Albert ManasyanUniversity of Alabama at Birmingham, Birmingham, Alabama, USA albertmanasyan@uabmc.edu.ORCID http://orcid.org/0000-0001-6275-245X
Tannia TemboCentre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Helen DaleU.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Jake M PryCentre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Megumi ItohU.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Dhelia WilliamsonU.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Herbert KapesaCentre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Josip DeradoU.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Rachel Suzanne BeardU.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Shilpa IyerCentre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Salome GassCentre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Annie MwilaU.S. Centers for Disease Control and Prevention, Lusaka, Zambia.
Michael E HerceCentre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.

Funding

CGH CDC HHS U01 GH000526
6 · The paper itself

Abstract

introductionAn estimated 800 000 children (<15 years) globally living with HIV remain undiagnosed. To reach these children with timely HIV testing services during infancy, we implemented a community-based differentiated care model using mobile point-of-care (POC) technology for early infant diagnosis (EID) of HIV, and assessed its effects on EID positivity, antiretroviral therapy (ART) initiation and 3-month retention in care.

methodsBetween 1 June 2019 and 31 May 2020 at six health facilities in Lusaka, Zambia, we enrolled mother-infant pairs (MIPs) at high risk for vertical transmission of HIV based on missing or late infant EID testing or other maternal risk factors. We offered these MIPs community POC EID testing (post-intervention), and compared their outcomes to historical high-risk controls at the same sites (1 June 2017-31 May 2018; pre-intervention). We used propensity score matched weighting and mixed effects regression modelling to estimate outcome differences pre-intervention and post-intervention, and to identify MIP characteristics predictive of vertical transmission of HIV.

results2577 MIPs were included in the analysis: 1763 and 814 high-risk MIPs from the pre-intervention and post-intervention periods, respectively. Infant HIV positivity was significantly higher in the post-intervention (2.2%) vs pre-intervention (1.1%) period (p=0.038), however this difference was attenuated (0.83%, 95% CI: -0.50%, 2.15%) after adjusting for differences in maternal age, maternal antenatal care visits, infant birth month and facility. During the post-intervention period, MIPs where the mother disengaged from care were 12.97 (95% CI: 2.41, 69.98) times as likely to have an infant diagnosed with HIV vs those in which the infant received late EID testing without maternal care disengagement. Among 18 infants diagnosed with HIV by the intervention, 16 (88.9%) initiated same-day ART and all continued ART at 3-month follow-up.

conclusionCommunity-based differentiated care employing POC EID technology increased testing positivity in unadjusted analyses, and resulted in high ART initiation and early care retention, suggesting it may be a promising approach for reaching infants and young children living with HIV being missed by current facility-based approaches. TRIAL REGISTRATION NUMBER: This trial is registered under the following Clinicaltrials.gov Identifier: NCT03133728.

Indexed as

Anti-Retroviral AgentsHIV InfectionsPoint-of-Care SystemsPoint-of-Care TestingAdultChild, PreschoolCohort StudiesEarly DiagnosisFemaleHumansInfantInfant, NewbornInfectious Disease Transmission, VerticalMaleZambiaAnti-Retroviral AgentsChild healthGlobal HealthHIVPCRScreening

Identifiers

PMID39979018
PMCPMC11842996

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.